Page last updated: 2024-11-06

prednisolone and Depressive Disorder, Major

prednisolone has been researched along with Depressive Disorder, Major in 6 studies

Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.

Depressive Disorder, Major: Disorder in which five (or more) of the following symptoms have been present during the same 2-week period and represent a change from previous functioning; at least one of the symptoms is either (1) depressed mood or (2) loss of interest or pleasure. Symptoms include: depressed mood most of the day, nearly every daily; markedly diminished interest or pleasure in activities most of the day, nearly every day; significant weight loss when not dieting or weight gain; Insomnia or hypersomnia nearly every day; psychomotor agitation or retardation nearly every day; fatigue or loss of energy nearly every day; feelings of worthlessness or excessive or inappropriate guilt; diminished ability to think or concentrate, or indecisiveness, nearly every day; or recurrent thoughts of death, recurrent suicidal ideation without a specific plan, or a suicide attempt. (DSM-5)

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (33.33)29.6817
2010's4 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Manohar, H1
Kuppili, PP1
Menon, V1
Normann, C1
Frase, L1
Berger, M1
Nissen, C1
Grover, S1
Aarya, KR1
Sharma, A1
Juruena, MF2
Cleare, AJ2
Papadopoulos, AS2
Poon, L2
Lightman, S2
Pariante, CM2
Laske, C1
Leyhe, T1
Buchkremer, G1
Wormstall, H1

Trials

2 trials available for prednisolone and Depressive Disorder, Major

ArticleYear
The prednisolone suppression test in depression: dose-response and changes with antidepressant treatment.
    Psychoneuroendocrinology, 2010, Volume: 35, Issue:10

    Topics: Antidepressive Agents; Depressive Disorder, Major; Dose-Response Relationship, Drug; Female; Glucoco

2010
Different responses to dexamethasone and prednisolone in the same depressed patients.
    Psychopharmacology, 2006, Volume: 189, Issue:2

    Topics: Area Under Curve; Depressive Disorder, Major; Dexamethasone; Female; Glucocorticoids; Humans; Hydroc

2006

Other Studies

4 other studies available for prednisolone and Depressive Disorder, Major

ArticleYear
Major depression: An under reported neuropsychiatric manifestation of Mixed Connective Tissue Disease.
    Asian journal of psychiatry, 2017, Volume: 30

    Topics: Antidepressive Agents, Second-Generation; Antimetabolites; Azathioprine; Citalopram; Depressive Diso

2017
Steroid-responsive depression.
    BMJ case reports, 2013, Apr-18, Volume: 2013

    Topics: Brain Diseases; Depressive Disorder, Major; Diagnosis, Differential; Electroencephalography; Encepha

2013
Use of electroconvulsive therapy in an adolescent with systemic lupus erythematosus for management of depression.
    The journal of ECT, 2013, Volume: 29, Issue:3

    Topics: Adolescent; Alkylating Agents; Anti-Inflammatory Agents; Antidepressive Agents, Second-Generation; A

2013
[Depression in Hashimoto's encephalopathy. Successful treatment of a severe depressive episode with a glucocorticoid as an add-on therapy].
    Der Nervenarzt, 2005, Volume: 76, Issue:5

    Topics: Aged; Chemotherapy, Adjuvant; Cyclohexanols; Depressive Disorder, Major; Drug Combinations; Female;

2005